BTLA Protein, Cynomolgus, Recombinant (His)
Ref. TM-TMPK-00530
| 1mg | 3,014.00 € | ||
| 100µg | 452.00 € | ||
| 500µg | 1,809.00 € |
Product Information
- MGC129743, CD272, BTLA, BTLA1, FLJ16065
B- and T-lymphocyte attenuator (BTLA; CD272) is a 35 kDa type I transmembrane glycoprotein in the CD28 family of T cell costimulatory molecules. BTLA is a inhibitory receptor on lymphocytes that negatively regulates antigen receptor signaling via PTPN6/SHP-1 and PTPN11/SHP-2. BTLA may interact in cis (on the same cell) or in trans (on other cells) with TNFRSF14. BTLA Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 15.04 kDa and the accession number is A0A2K5W7M7.
Chemical properties
Technical inquiry about: TM-TMPK-00530 BTLA Protein, Cynomolgus, Recombinant (His)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
